New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
The selection of individuals for federal health agencies under President-elect Donald Trump presents conflicting views on matters such as abortion limits, vaccine safety, covid-19 responses, and the use of weight-loss medications.
Physician compensation remains a central concern in health care, influenced by educational debt, specialty-specific variations, and evolving employer policies.